| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. | JAMA | 2010 | 2.75 |
| 2 | Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. | Pediatr Pulmonol | 2012 | 2.08 |
| 3 | Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. | Chest | 2012 | 0.95 |
| 4 | A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. | Pediatrics | 2012 | 0.89 |
| 5 | Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis. | J Clin Microbiol | 2011 | 0.78 |
| 6 | Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials. | Contemp Clin Trials | 2013 | 0.76 |
| 7 | Response to letter. | Pediatr Pulmonol | 2014 | 0.75 |